ArticleArchives of microbiology2025
Optimization and scalable production of Corynebacterium diphtheriae toxin using an animal component free medium: a pathway towards safer vaccine development.
Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effective treatment of human breast tumors by chimeric CCL2 and CCL8 diphtheria toxin cytotoxic peptides.Cancer biology & therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diphtheria is an infectious disease causing severe illness, particularly in children, which can be prevented by vaccination with diphtheria toxoid, a detoxified derivative form of diphtheria toxin. The present study aimed to overcome the limitations of traditional animal-derived medium and to enhance diphtheria toxin production by refining the various process parameters and iron concentration of semi-synthetic medium. The iron concentration in the medium was investigated in the range of 0.05 to 0.6 µg/mL, and an ideal concentration was found to be 0.4 µg/mL, where 221 ± 7.6 Lf/mL of DT was obtained. Response Surface Methodology was used to further optimize physical parameters such as pH, temperature, agitation speed, and concentration of inoculum. A central composite design comprising 30 experimental runs identified the best conditions as pH 7.2, temperature 35 °C, agitation speed 150 rpm, and 5.8% inoculum concentration yielding a maximum DT yield of 245 ± 5 Lf/mL. To validate scalability, a 5 L stirred-tank bioreactor was used to assess the influence of aeration and agitation on biomass and diphtheria toxin production were studied. At 600 rpm and 0.25 VVM, a maximum of 266 Lf/mL of diphtheria toxin was obtained. The biomass and toxin yields were adversely affected by higher aeration and agitation. This study highlights the significance of optimizing process parameters and establishing a scalable strategy for efficient production of diphtheria toxin using animal component-free medium.
Indexed as
Identifiers
41081812What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.